API seeks to consolidate the market

Australian Pharmaceutical Industries (API), headquartered at Camellia, is interested in acquiring the vitamins and wholesale drug distribution of Primary Health Care. “We’ve always said we supported consolidation in the pharmaceutical market,” said MD, Stephen Roche. API delivered a first-half net profit of $6.15 million to February. The company’s supply chain is undergoing a three-year reorganisation which will cost $60 million and deliver annual savings of $18 million from 2011.